QQQ   439.07 (+0.87%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.97 (+1.44%)
GOOGL   138.49 (+1.55%)
AMZN   176.89 (+2.15%)
TSLA   201.88 (-0.08%)
NVDA   791.71 (+1.94%)
NIO   5.75 (+5.89%)
AMD   192.81 (+9.22%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.60 (+0.99%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.07 (+0.87%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.97 (+1.44%)
GOOGL   138.49 (+1.55%)
AMZN   176.89 (+2.15%)
TSLA   201.88 (-0.08%)
NVDA   791.71 (+1.94%)
NIO   5.75 (+5.89%)
AMD   192.81 (+9.22%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.60 (+0.99%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.07 (+0.87%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.97 (+1.44%)
GOOGL   138.49 (+1.55%)
AMZN   176.89 (+2.15%)
TSLA   201.88 (-0.08%)
NVDA   791.71 (+1.94%)
NIO   5.75 (+5.89%)
AMD   192.81 (+9.22%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.60 (+0.99%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.07 (+0.87%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.97 (+1.44%)
GOOGL   138.49 (+1.55%)
AMZN   176.89 (+2.15%)
TSLA   201.88 (-0.08%)
NVDA   791.71 (+1.94%)
NIO   5.75 (+5.89%)
AMD   192.81 (+9.22%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.60 (+0.99%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
NASDAQ:VBLT

Vascular Biogenics (VBLT) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$5.34
$6.74
50-Day Range
$0.16
$5.46
52-Week Range
$0.10
$6.74
Volume
161,505 shs
Average Volume
2.19 million shs
Market Capitalization
$423.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

VBLT stock logo

About Vascular Biogenics Stock (NASDAQ:VBLT)

Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.


VBLT Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Vascular Biogenics Rises on Presentation Hype
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Vascular Biogenics (NASDAQ: VBLT)
Why Is Vascular Biogenics (VBLT) Stock Up 52%?
See More Headlines
Receive VBLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vascular Biogenics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
2/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VBLT
Previous Symbol
NASDAQ:VBLX
Employees
7
Year Founded
N/A

Profitability

Net Income
$-32,300,000.00
Pretax Margin
-3,317.05%

Debt

Sales & Book Value

Annual Sales
$660,000.00
Book Value
$0.32 per share

Miscellaneous

Free Float
72,881,000
Market Cap
$423.91 million
Optionable
Optionable
Beta
0.77
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Prof. Dror Harats M.D. (Age 66)
    CEO & Director
    Comp: $444.33k
  • Mr. Samuel Backenroth (Age 39)
    Chief Financial Officer
    Comp: $410k
  • Dr. Eyal Breitbart Ph.D. (Age 56)
    Sr. VP of Research & Operations
  • Advocate Ayelet Horn (Age 52)
    Gen. Counsel
  • Dr. Erez Feige M.B.A. (Age 49)
    Ph.D., Sr. VP of Bus. Operations














VBLT Stock Analysis - Frequently Asked Questions

How were Vascular Biogenics' earnings last quarter?

Vascular Biogenics Ltd. (NASDAQ:VBLT) issued its quarterly earnings data on Monday, November, 15th. The biopharmaceutical company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.02. The biopharmaceutical company earned $0.20 million during the quarter, compared to the consensus estimate of $0.20 million. During the same period in the previous year, the company posted ($0.12) earnings per share.

What other stocks do shareholders of Vascular Biogenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vascular Biogenics investors own include SCYNEXIS (SCYX), Matinas BioPharma (MTNB), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Aeterna Zentaris (AEZS), Dynavax Technologies (DVAX), Vaxart (VXRT) and Geron (GERN).

This page (NASDAQ:VBLT) was last updated on 2/29/2024 by MarketBeat.com Staff